CarnaLife Holo has already supported doctors in almost 200 complex medical procedures. In recent days, the team led by prof. dr Jerzy Sacha, cardiologist at the University Clinical Hospital (USK) in Opole and professor at the Opole University of Technology, performed another innovative procedure in “mixed reality” using the CarnaLife Holo technology of holographic visualizations, such as those we have known so far from “Star Trek”, the popular science fiction media franchise.
“Using MedApp’s unique CarnaLife Holo technology, we obtained holographic images of the inside of the heart, which we used to perform a minimally invasive mitral valve repair procedure without opening the chest, using the MitraClip system. The unique nature of this procedure was that a 3D holographic image of the heart’s internal structures was used in real time, i.e., during mitral valve repair surgery. So far, holography has mainly been used at the stage of preparation for surgery,” explains prof. Jerzy Sacha, head of the Hemodynamic Research Laboratory at USK in Opole.
The hologram was displayed in the operating room by MedApp’s CarnaLife Holo software, paired with special HoloLens 2 glasses from Microsoft.
“CarnaLife Holo is a breakthrough technology for three-dimensional visualization of medical imaging data, providing access to images in the form of holograms throughout the surgery, which can significantly reduce its duration and thus bring measurable benefits to the patient, medical staff and the hospital,” adds Krzysztof Mędrala, CEO of MedApp S.A.
The hospital in Opole is the second medical center in the world which performed a MitraClip procedure using holographic imaging, after the team from one of the largest hospitals in Europe – AKH in Vienna. The solution has already been recognized by the international medical community, receiving an honorable mention as “Best Case 2021” at the PCR London Valves 2021 international conference.
The procedure at USK in Opole was performed by: prof. dr Jerzy Sacha, dr Krzysztof Krawczyk, and dr Jarosław Bugajski (cardiologists); dr Mateusz Stanisz (anesthesiologist); Monika Świderska and Małgorzata Werner (assistants); Danuta Radiszewska (anesthesiology nurse); Filip Żuczek (X-ray technician); Szymon Dziedzic (Abbott company). Technological support was provided by Jakub Kasprzak and Kacper Pabianek from MedApp and Tomasz Ogonowski from GE.
“We are proud that the pioneering procedure, using the latest medical and supportive technologies, was carried out at our hospital,” comments Dariusz Madera, General Manager of USK in Opole. “Congratulations to the entire team, led by Professor Jerzy Sacha.”
It is also worth noting that this was not the first innovative minimally invasive interventional cardiology procedure carried out at USK in Opole. Recently at conferences in Orlando, USA and London, prof. Sacha presented the results a heart assist pump (Impella) implantation and aortic valve implantation with TAVI through the subclavian artery.
Read more See similar articles:
MedApp is the laureate of the Special Award of PARP and NCBR
During the Gala of the 24th edition of the Polish Product of the Future competition, we received a special award from the Polish Agency for Enterprise Development and the National Center for Research and Development!
East Value Research Analyst Report – update
An independent analyst report prepared by analysts at East Value Research was released today.
MedApp with record FY 2021 results, doubling revenue and profits from previous year
MedApp reported PLN 12.7 million in net sales revenue cumulatively after four quarters of 2021, 111% higher than a year earlier. EBITDA increased by 139% to PLN 6.3 million, and net profit was twice higher year-on-year, reaching PLN 3.8 million. The company also boasts high profitability.